Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOREN A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.9% 1.9%   Bankruptcy risk   2.1% 3.7% 2.2% 2.5% 5.0% 3.9% 14.0% 13.9%   Credit score (0-100)   68 53 66 61 43 50 3 3   Credit rating   BBB BB BBB BBB BB BB B B   Credit limit (kDKK)   0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   79.3 95.5 40.5 169 271 35.6 0.0 0.0   EBITDA   75.4 84.4 24.3 165 205 -91.5 0.0 0.0   EBIT   31.1 40.0 -20.1 131 180 -121 0.0 0.0   Pre-tax profit (PTP)   48.2 -8.4 128.3 -30.6 -114.9 -27.6 0.0 0.0   Net earnings   35.1 -7.5 98.5 -23.6 -113.6 -23.1 0.0 0.0   Pre-tax profit without non-rec. items   48.2 -8.4 128 -30.6 -115 -27.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   162 168 124 89.3 63.5 94.4 0.0 0.0   Shareholders equity total   1,237 1,230 1,328 1,304 1,191 1,168 668 668   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,271 1,410 1,357 1,310 1,390 1,215 668 668   Net Debt   -842 -877 -994 -1,018 -869 -854 -668 -668     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   79.3 95.5 40.5 169 271 35.6 0.0 0.0   Gross profit growth   -61.2% 20.4% -57.6% 318.5% 60.1% -86.9% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   -3.9 -11.2 -16.2 -4.3 -65.9 -127.2 0.0 0.0   Balance sheet total (assets)   1,271 1,410 1,357 1,310 1,390 1,215 668 668   Balance sheet change%   -5.6% 10.9% -3.8% -3.4% 6.1% -12.6% -45.0% 0.0%   Added value   35.0 51.1 -3.9 135.3 245.5 6.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -89 -39 -89 -68 -52 2 -94 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   39.2% 41.8% -49.6% 77.3% 66.2% -338.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.7% 7.9% 9.3% 29.6% 36.6% -2.1% 0.0% 0.0%   ROI %   4.0% -0.7% 10.0% -2.2% -8.9% -2.3% 0.0% 0.0%   ROE %   2.9% -0.6% 7.7% -1.8% -9.1% -2.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   97.3% 87.2% 97.9% 99.5% 85.7% 96.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,116.6% -1,040.1% -4,088.1% -616.7% -422.8% 933.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   59.2 6.3 57.8 422.4 5.4 20.4 0.0 0.0   Current Ratio   66.4 7.4 66.6 473.6 6.8 23.8 0.0 0.0   Cash and cash equivalent   841.9 877.4 993.7 1,018.2 868.7 854.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   854.7 893.9 424.2 440.7 675.1 535.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0